News and Announcements
Fintech startup, Pelikin, changing the face of prepaid VISA cards and insurance for Australian travellers
- Published September 18, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Highlights
- Pelikin, created for young Australian travellers, is making the use of prepaid visa cards around the world a much simpler process.
- The prepaid visa card pairs with a smartphone app that can be used around the world in any currency, void of any international transaction fees.
- Pelikin has announced a partnership with Travel By Us to offer travel insurance for its users, all managed within the app.
- Pelikin Travel Insurance will be underwritten by Lloyds and is launching in late September.
- Pelikin is available on the Google and Apple App Stores, in invite only mode until it’s official market launch in October 2019.
Australian fintech start-up Pelikin is making the use of prepaid visa cards around the world a much simpler process. Pelikin is a prepaid visa card that pairs with a smartphone app that can be used around the world and void of any international transaction fees. This easy to load card allows users to make multiple transactions in multiple currencies and split bills in whatever currency they require.
Pelikin was created by young Aussies who travel and made for young Aussies who travel, dedicated to providing an end-to-end platform for young Aussie travellers. The partnership with Travel By Us allows Pelikin to offer travel insurance for its users, all managed within the app. It offers a broad range of insurance packages from the young to elderly, those with medical conditions, those who are pregnant and those looking for extra cover for certain activities.
Next is an official launch within Australia with the product due for release in October 2019.
Pelikin is available on the Google and Apple App Stores, in invite only mode until it’s official market launch in October 2019.
To keep up to date with Pelikin, register your interest in the company below.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
